James Potter’s Post

Good Evening Everyone, 🚀 Unlocking the Future of Healthcare: A Deep Dive into India's Pharmaceutical Industry! 🌍💊 🚀 Day 15 of the Industrial analysis Thank you & Stay Connected 👉SWIPE to know more about this industry #Linkedin #Equityresearch #Capitalmarkets #Day15 #Industryanalysis #Pharmaceuticalindustry

My thoughts in a new post that was published Medium. 🌟 The pharmaceutical industry is at a pivotal crossroads where soaring healthcare costs and demands for innovation are reshaping traditional investment paradigms. 💡 From precision medicine to value-based pricing, the future of pharma hinges on strategic adaptation to new market dynamics, making it crucial for stakeholders to rethink their approach to both investment and returns. #Pharma #HealthcareInnovation #IndustryTrends

Unveiling the Hidden Gems: Exploring the Untapped Potential of Pharmaceutical Patent Innovation. In a world of constant advancements, let's delve into how pharmaceutical patent innovation is reshaping the industry landscape. From novel drug delivery systems to groundbreaking treatment methods, the possibilities are endless. Embrace the future of healthcare by unlocking the power of intellectual property in the pharmaceutical realm. Let's innovate, collaborate, and pave the way for a healthier tomorrow. 💊💡 #PharmaceuticalInnovation #PatentProgress #HealthcareRevolution

A2 Healthcare is among the top CROs that dominate the Japanese market, with their market share continuing to grow as reported by the European Pharmaceutical Review in 2020. Researchers emphasize that outsourcing research facilities will play a key role in the clinical trial space, with major CROs exercising their power to choose clients. Having increased its presence in the United States, A2 is rapidly becoming a leading Japanese CRO with global reach to meet the need for wider capability. Visit the website to learn more about A2 Healthcare's vision. https://lnkd.in/ghJHJKrk #JapaneseCRO #Pharmaceutical #Biotech #PipelineAccelerator #BostonBiotech #PharmaInnovation #DrugDevelopment #DrugDiscovery

How exciting!!! My first article for Branding Science is now live. It is a build on the thinking I have been chewing over for the last year or so. Next step is to create a Lunch and Learn on better ways to look at the future to support pipeline and product planning for pharmaceutical, health AI and digital health products. I hope that you find this interesting. #healthfutures #pharmaMR

Why do we ask doctors to predict the future when humans can’t? The pharmaceutical insights industry has used fundamentally the same questions for a long time in our research to support pipeline decisions and planning. Questions like: - How likely are you to use this product?  - What percentage of patients would you use it for? Is it time to reframe these questions to provide more insightful results? In this article, Branding Science’s Senior Client Services Director, Lucy Ireland, questions the traditional approach of relying on doctors to predict the future use of pharmaceutical products (in Demand studies, Target Product Profile tests etc), proposing a shift in the wording to generate arguably more accurate and definitely more insightful results. The full article can be found below. #Pharma #HealthcareInsights #Blog

With a greater focus on innovation and expansion of local manufacturing, the LATAM market (currently at $98 billion dollars) offers an attractive destination for domestic and international pharmaceutical companies. However, barriers remain, including technology gaps, supply chain constraints and a high dependence on API imports. Learn how internationalization, incremental innovation and more can impact transformation in the region and shape the future in a new whitepaper centered on the latest hurdles and potential solutions facing LATAM, here: https://lnkd.in/gdgbJ694 #LATAM #pharmaceutical #API #supplychain #clinicaltrials

🚀 #RealWorldEvidence is transforming pharmaceutical #DrugDevelopment, making it faster, safer, and more relevant than ever before! 💊 In an industry where innovation comes at a high cost and success rates are modest, #RWE emerges as a game-changer. By leveraging #RealWorldData, we can navigate the hurdles of drug development with greater efficiency and precision. Here’s how #RWE is reshaping the landscape 👉 https://bit.ly/3JsqN4l

With its rapidly growing economy, massive population, and increasing focus on healthcare, China has set its sights on becoming a world leader in pharmaceutical innovation. However, this journey is not without its challenges. In this comprehensive article, we’ll explore the obstacles and opportunities that define Chinese pharmaceutical innovation, and how the industry is working to overcome barriers and capitalize on its unique advantages. https://lnkd.in/eKiBH-Ka

Tata Group is no small name in Pharmaceutical industry! 💊 Our research uncovers Tata Group's lesser-known yet impactful journey in healthcare, from drug discovery to innovative therapies and beyond. Discover how they continue to shape the industry. ✒ Parth A. For more research like this, follow Penguin International 📲 #TataGroup #HealthcareInnovation #PharmaceuticalResearch #DrugDiscovery #HealthcareSector #ManagementConsulting #IndustryInsights #CorporateStrategy #DigitalHealth #MedicalDevices #HealthcareServices #ConsultingResearch #EconomicImpact #BusinessStrategy #HealthcareInvestment #InnovationLeadership #TataHealthcare #PenguinInternational